PINK1 and Parkinson disease: Some researchers even use skin fibroblast from PD patients and the control lines with knock-down of PINK1, to investigate the expression changes of SCNA, they reveal that the expression changes detected from the two lines of cell may have the potential to see as a biomarker that allow physician to diagnosis objective PD in an non-invasive way (Hoepken et al., 2008).